自動注射器の世界市場レポート 2025年

自動注射器市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR22.0%で100億7,000万米ドルに成長します。予測期間の成長は、治療用途の拡大、医療コストの上昇、患者中心のケアへの注目の高まり、遠隔医療と遠隔患者モニタリング、新興市場に起因します。予測期間の主要動向には、個別化ドラッグデリバリー、コネクテッド＆スマート自動注射器、無針自動注射器、生物製剤デリバリー、安全セキュリティ機能などがあります。

慢性疾患の増加により、今後数年間は自動注射器市場の成長が見込まれます。慢性疾患とは、1年以上持続し、継続的な医療的治療を必要とする病気と定義されます。心臓病、がん、関節リウマチ、糖尿病などの疾患は、世界の死亡率や身体障害の主要原因となっています。自動注射器は、糖尿病や関節リウマチのような疾患の長期管理のために定期的な投与が必要な患者に、生物製剤やホルモンを複数回注射するために設計されています。例えば、2022年1月に米国を拠点とする健康団体である米国がん協会が発表した調査結果によると、その年の米国におけるがん死亡者数は60万9,360人、新規がん罹患者数は190万人と予測されており、これは毎日約1,670人が死亡していることになります。定期的な投薬が必要な患者にとって、これらの機器は便利で効果的なソリューションを提供するため、慢性疾患の有病率の上昇が自動注射器市場の成長を促進しています。

医療支出の増加が自動注射器市場を押し上げると予測されています。医療支出とは、特定の医療システムや経済圏において、一定期間に医療サービス、物品、活動に費やされる総額のことです。医療支出の増加は、自動注射器の開発、手頃な価格、患者へのアクセシビリティをサポートします。さらに、自動注射器に対する需要の増大は、自動注射器開発のセグメントにおける技術革新を促進します。一例として、英国国家統計局が2023年5月に発表した報告書によると、英国の医療支出は2020～2021年にかけて名目で9.4％、実質で9.7％増加しました。2021年には、英国の総医療支出は3,672億5,000万米ドル（2,807億英ポンド）に達し、医薬品支出は518億4,000万米ドル（396億英ポンド）、予防医療への支出は2020年の2倍以上となる459億3,000万米ドル（351億英ポンド）に達します。このように、医療支出の増加は自動注射器市場の推進に大きな役割を果たしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の自動注射器PESTEL分析（政治、社会、技術、環境、法的、促進要因、制約要因）
• 最終用途産業の分析
• 世界の自動注射器市場成長率分析
• 世界の自動注射器市場の実績：規模と成長、2019～2024年
• 世界の自動注射器市場の予測：規模と成長、2024～2029年、2034年
• 世界の自動注射器総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の自動注射器市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 使い捨て自動注射器
• 再利用可能自動注射器
• 世界の自動注射器市場：療法別、実績と予測、2019～2024年、2024～2029年、2034年
• 関節リウマチ
• 多発性硬化症
• 糖尿病
• アナフィラキシー
• その他
• 世界の自動注射器市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 皮下
• 筋肉内
• 世界の自動注射器市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• オンライン小売業者
• 薬局
• 世界の自動注射器市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 在宅医療
• 病院とクリニック
• その他
• 世界の自動注射器市場、使い捨て自動注射器のサブセグメンテーション、タイプ別実績と予測、2019～2024年、2024～2029年、2034年
• 使い捨て自動注射器
• プレフィルド使い捨て自動注射器
• 世界の自動注射器市場、再利用可能自動注射器のサブセグメンテーション、タイプ別実績と予測、2019～2024年、2024～2029年、2034年
• 多用途再利用可能自動注射器
• 充電式再利用可能自動注射器

第7章 地域別・国別分析

• 世界の自動注射器市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の自動注射器市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 自動注射器市場：競合情勢
• 自動注射器市場：企業プロファイル
  • AbbVie Inc.
  • Mylan N.V.
  • Eli Lilly and Company
  • Amgen Inc.
  • Becton, Dickinson and Company

第31章 その他の大手企業と革新的企業

• Johnson & Johnson
• Teva Pharmaceutical Industries Ltd.
• Merck & Co. Inc.
• Pfizer Inc.
• Bayer AG
• Biogen Inc.
• AstraZeneca PLC
• Haselmeier GmbH
• Owen Mumford Ltd.
• Gerresheimer AG
• Philip Morris International Inc.
• Oval Medical Technologies Ltd.
• Solteam Incorporation Co. Ltd.
• Elcam Medical Group（E3D）Ltd.
• Jabil Inc.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、戦略

• 自動注射器市場、2029年-最も新しい機会を提供する国
• 自動注射器市場、2029年-最も新しい機会を提供するセグメント
• 自動注射器市場、2029年-成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

An autoinjector is a device designed for self-administering a single, predetermined dose of medication into the body. Typically, it features a spring-loaded syringe that is activated upon firm pressure against the body.

The primary types of autoinjectors are disposable autoinjectors and reusable autoinjectors. The market for disposable autoinjectors involves the sales of devices designed to replace traditional pre-filled syringes, aiming to eliminate psychological barriers by concealing the needle from the patient's view. These autoinjectors integrate a spring-powered mechanism with a shielded needle for subcutaneous or intramuscular administration of the required drug solution. They find application in various therapies such as rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others, administered through routes like subcutaneous and intramuscular. Distribution channels include online retailers and pharmacies, and they are utilized in diverse settings, including home care, hospitals, clinics, and others.

The autoinjectors market research report is one of a series of new reports from The Business Research Company that provides autoinjectors market statistics, including autoinjectors industry global market size, regional shares, competitors with an market share, detailed autoinjectors market segments, market trends and opportunities, and any further data you may need to thrive in the autoinjectors industry. This autoinjectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoinjectors market size has grown exponentially in recent years. It will grow from $3.7 billion in 2024 to $4.55 billion in 2025 at a compound annual growth rate (CAGR) of 22.8%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, growth in aging population, rise in biotechnology and pharmaceutical sector, rise in patient preference for self-administration, regulatory support.

The autoinjectors market size is expected to see exponential growth in the next few years. It will grow to $10.07 billion in 2029 at a compound annual growth rate (CAGR) of 22.0%. The growth in the forecast period can be attributed to expansion of Therapeutic applications, rising healthcare costs, increased focus on patient-centered care, telemedicine and remote patient monitoring, emerging markets. Major trends in the forecast period include personalized drug delivery, connected and smart autoinjectors, needle-free autoinjectors, biologic drug delivery, safety and security features.

The rising prevalence of chronic diseases is expected to drive growth in the autoinjectors market in the upcoming years. Chronic diseases are defined as illnesses that last for a year or longer and require ongoing medical attention. Conditions such as heart disease, cancer, rheumatoid arthritis, and diabetes are among the leading causes of mortality and disability worldwide. Autoinjector devices are designed for multiple injections of biologics and hormones in patients who need regular doses for the long-term management of conditions like diabetes and rheumatoid arthritis. For example, in January 2022, research published by the American Cancer Society, a US-based health organization, projected that there would be 609,360 cancer deaths and 1.9 million new cancer cases in the US for that year, which translates to approximately 1,670 fatalities each day. This rising prevalence of chronic diseases is propelling the growth of the autoinjectors market, as these devices offer a convenient and effective solution for patients requiring regular medication.

Rising healthcare expenditure is anticipated to boost the autoinjectors market. Healthcare expenditure refers to the total amount of money spent on healthcare services, goods, and activities within a specific healthcare system or economy over a defined period. Increased healthcare expenditure supports the development, affordability, and accessibility of autoinjectors for patients. Moreover, greater demand for autoinjectors can drive innovation in the field of autoinjector development. As an illustration, according to a report published by the UK's Office for National Statistics in May 2023, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021. In 2021, total healthcare expenditure in the UK reached $367.25 billion (£280.7 billion), with pharmaceutical expenditure at $51.84 billion (£39.6 billion), and spending on preventive care more than doubling from 2020, totaling $45.93 billion (£35.1 billion). Thus, rising healthcare expenditures are playing a significant role in propelling the autoinjectors market.

The rise of technological advancements is significantly influencing the autoinjectors market. Key players in the autoinjectors sector are concentrating on developing innovative solutions to fulfill the demand for a delivery mechanism for viscous biologics. For example, in May 2023, Boehringer Ingelheim, a Germany-based pharmaceutical company, announced that its Cyltezo Pen, an autoinjector option for Cyltezo (adalimumab-adbm), received approval from the U.S. Food and Drug Administration (FDA). Cyltezo is authorized for the treatment of various chronic inflammatory diseases. The 40 mg/0.8 mL pre-filled Cyltezo Pen will be available in packs of two, four, and six.

Major companies in the auto-injectors market are focused on developing innovative products to address the growing demand for sustainable drug delivery devices while offering more cost-effective solutions for self-administered drug delivery. One such innovative product is the Qfinity auto-injector platform, designed to be both sustainable and affordable. The platform incorporates durable materials capable of withstanding over 100 injections and features a pre-filled disposable cassette system that minimizes waste. For example, in May 2022, Jabil Inc., a US-based healthcare manufacturing company, introduced the Qfinity auto-injector platform. This platform is a straightforward, reusable, and modular solution for self-administering subcutaneous (SC) drugs, including larger-volume and higher-viscosity medicines. It offers sustainability, cost-effectiveness, versatility, ease of use, accuracy, safety, portability, and durability for self-administered drug delivery.

In April 2022, Halozyme Therapeutics Inc., a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million. This strategic acquisition is aimed at expanding Halozyme Therapeutics Inc.'s portfolio of drug delivery technologies and gaining access to Antares' commercial infrastructure. The acquisition positions them to become a leading company in the field of drug delivery. Antares Pharma Inc. is a US-based pharmaceutical product development company specializing in the development of auto-injectors. This acquisition will likely enhance Halozyme's capabilities in delivering innovative drug delivery solutions, including auto-injectors, to a broader market.

Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc

North America was the largest region in the autoinjectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in autoinjectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the autoinjectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The autoinjectors market consists of sales of disposable and reusable autoinjectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autoinjectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoinjectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoinjectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autoinjectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Disposable Autoinjectors; Reusable Autoinjectors
• 2) By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies
• 3) By Route Of Administration: Subcutaneous; Intramuscular
• 4) By Distribution Channel: Online Retailer; Pharmacy
• 5) By End User: Home Care Settings; Hospitals And Clinics; Other End-Users
• Subsegments:
• 1) By Disposable Autoinjectors: Single-Use Disposable Autoinjectors; Pre-filled Disposable Autoinjectors
• 2) By Reusable Autoinjectors: Multi-Use Reusable Autoinjectors; Rechargeable Reusable Autoinjectors
• Companies Mentioned: AbbVie Inc.; Mylan N.V.; Eli Lilly and Company; Amgen Inc.; Becton, Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autoinjectors Market Characteristics

3. Autoinjectors Market Trends And Strategies

4. Autoinjectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Autoinjectors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Autoinjectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Autoinjectors Market Growth Rate Analysis
• 5.4. Global Autoinjectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Autoinjectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Autoinjectors Total Addressable Market (TAM)

6. Autoinjectors Market Segmentation

• 6.1. Global Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable Autoinjectors
• Reusable Autoinjectors
• 6.2. Global Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rheumatoid Arthritis
• Multiple Sclerosis
• Diabetes
• Anaphylaxis
• Other Therapies
• 6.3. Global Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous
• Intramuscular
• 6.4. Global Autoinjectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Retailer
• Pharmacy
• 6.5. Global Autoinjectors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Home Care Settings
• Hospitals And Clinics
• Other End-Users
• 6.6. Global Autoinjectors Market, Sub-Segmentation Of Disposable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Disposable Autoinjectors
• Pre-filled Disposable Autoinjectors
• 6.7. Global Autoinjectors Market, Sub-Segmentation Of Reusable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-Use Reusable Autoinjectors
• Rechargeable Reusable Autoinjectors

7. Autoinjectors Market Regional And Country Analysis

• 7.1. Global Autoinjectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Autoinjectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autoinjectors Market

• 8.1. Asia-Pacific Autoinjectors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autoinjectors Market

• 9.1. China Autoinjectors Market Overview
• 9.2. China Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autoinjectors Market

• 10.1. India Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autoinjectors Market

• 11.1. Japan Autoinjectors Market Overview
• 11.2. Japan Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autoinjectors Market

• 12.1. Australia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autoinjectors Market

• 13.1. Indonesia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autoinjectors Market

• 14.1. South Korea Autoinjectors Market Overview
• 14.2. South Korea Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autoinjectors Market

• 15.1. Western Europe Autoinjectors Market Overview
• 15.2. Western Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autoinjectors Market

• 16.1. UK Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autoinjectors Market

• 17.1. Germany Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autoinjectors Market

• 18.1. France Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autoinjectors Market

• 19.1. Italy Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autoinjectors Market

• 20.1. Spain Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autoinjectors Market

• 21.1. Eastern Europe Autoinjectors Market Overview
• 21.2. Eastern Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autoinjectors Market

• 22.1. Russia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autoinjectors Market

• 23.1. North America Autoinjectors Market Overview
• 23.2. North America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autoinjectors Market

• 24.1. USA Autoinjectors Market Overview
• 24.2. USA Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autoinjectors Market

• 25.1. Canada Autoinjectors Market Overview
• 25.2. Canada Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autoinjectors Market

• 26.1. South America Autoinjectors Market Overview
• 26.2. South America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autoinjectors Market

• 27.1. Brazil Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autoinjectors Market

• 28.1. Middle East Autoinjectors Market Overview
• 28.2. Middle East Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autoinjectors Market

• 29.1. Africa Autoinjectors Market Overview
• 29.2. Africa Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autoinjectors Market Competitive Landscape And Company Profiles

• 30.1. Autoinjectors Market Competitive Landscape
• 30.2. Autoinjectors Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Autoinjectors Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Merck & Co. Inc.
• 31.4. Pfizer Inc.
• 31.5. Bayer AG
• 31.6. Biogen Inc.
• 31.7. AstraZeneca PLC
• 31.8. Haselmeier GmbH
• 31.9. Owen Mumford Ltd.
• 31.10. Gerresheimer AG
• 31.11. Philip Morris International Inc.
• 31.12. Oval Medical Technologies Ltd.
• 31.13. Solteam Incorporation Co. Ltd.
• 31.14. Elcam Medical Group (E3D) Ltd.
• 31.15. Jabil Inc.

32. Global Autoinjectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autoinjectors Market

34. Recent Developments In The Autoinjectors Market

35. Autoinjectors Market High Potential Countries, Segments and Strategies

• 35.1 Autoinjectors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Autoinjectors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Autoinjectors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer